Clinical Trials Browser

Completed × INDUSTRY × anlotinib × Clear all

NCT05301764 2026-05-20

A Study of LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Phase 1/2 Completed

Sarcoma

NCT04574284 2025-05-28

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer

Phase 2 Completed

Advanced Endometrial Cancer

NCT04216082 2020-01-02

A Study of Anlotinib in Subjects With Advanced Malignancy

Phase 2 Completed

Advanced Malignancy

NCT02649361 2019-06-05

Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01878448 2019-05-22

ALTN/STS

Phase 2 Completed

Neoplasms

NCT02825563 2019-05-22

A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients

Phase 1 Completed

Advanced Cancer

NCT01874873 2019-05-21

ALTN/MTC

Phase 2 Completed

Neoplasms

NCT02332499 2019-05-21

ALTER0703

Phase 2/3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02586350 2019-05-21

Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)

Phase 2/3 Completed

Carcinoma, Medullary

NCT03059797 2019-05-16

Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)

Phase 2 Completed

Small Cell Lung Carcinoma

NCT02622932 2019-04-30

Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT02388919 2017-09-18

ALTER0303

Phase 2/3 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT01833923 2015-10-28

ALTN

Phase 1 Completed

Advanced Cancer

NCT01924195 2015-10-28

Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasms